Cycle tracking wearables are being asked to prove clinical grade accuracy, not just convenience
DDDr. Dereck Mush, MD, MBA
May 21
What they do
Mira produces an FDA-compliant at-home health monitor that quantitatively measures key fertility hormones like luteinizing hormone and estrogen from urine. The device syncs with an AI-powered application to predict fertile windows and assist individuals navigating pregnancy planning or menopause.
The record
- Vertical
- Women's Health
- Sub-segment
- At-home hormone tracking
- Product type
- Device
- Stage
- Series A
- Headquarters
- San Francisco, USA
- Region
- North America
- Founded
- 2015
- Total funding
- $10M raised
Notable investors: Y Combinator, Xinghang Capital.
Also in Women's Health
Related on The Signal
The HealthTech Signal
At-home semen analysis is turning a taboo test into a routine one
At-home semen analysis is turning a taboo test into a routine one
DDDr. Dereck Mush, MD, MBA
Sep 1
Telehealth testosterone care is scaling faster than the guidelines that govern it
DDDr. Dereck Mush, MD, MBA
Jul 14
Midi Health raises $100 million and stops calling itself a menopause company
DDDr. Dereck Mush, MD, MBA
Aug 28